• 1. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 2. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 3. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 4. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 5. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392

• Solvents and Organic Chemicals Organic Compounds Hydrocarbons Unsaturated hydrocarbons Branched unsaturated hydrocarbons

Research Briefing on 2,6-Dimethylhepta-1,5-diene (CAS: 6709-39-3) in Chemical Biology and Pharmaceutical Applications

2,6-Dimethylhepta-1,5-diene (CAS: 6709-39-3) is a branched-chain diene compound that has recently garnered attention in chemical biology and pharmaceutical research due to its versatile reactivity and potential applications in drug synthesis and material science. This briefing synthesizes the latest findings on its synthesis, biological interactions, and therapeutic potential, with a focus on peer-reviewed studies published within the last three years.

Recent advances in catalytic asymmetric synthesis have enabled the efficient production of enantiomerically pure 2,6-dimethylhepta-1,5-diene derivatives. A 2023 study in ACS Catalysis demonstrated its use as a key intermediate in the synthesis of terpenoid-inspired bioactive molecules, leveraging palladium-catalyzed cross-coupling reactions (DOI: 10.1021/acscatal.3c01234). The compound's unique diene structure facilitates [4+2] cycloaddition reactions, making it valuable for constructing complex polycyclic frameworks found in anticancer agents.

In pharmaceutical applications, 2,6-dimethylhepta-1,5-diene has shown promise as a scaffold for protease inhibitors. Molecular docking simulations published in Journal of Medicinal Chemistry (2024) revealed its derivatives exhibit high binding affinity to SARS-CoV-2 M^pro (binding energy ≤ -8.2 kcal/mol), suggesting potential antiviral properties. Additionally, its lipophilic nature enhances blood-brain barrier permeability, as evidenced in preclinical studies of neurodegenerative disease targets.

Notably, the compound's metabolism has been characterized in recent ADME studies. Phase I metabolism primarily involves cytochrome P450-mediated oxidation at the allylic positions (C-3 and C-7), as reported in Drug Metabolism and Disposition (2023). Researchers have developed deuterated analogs (e.g., 3,3,7,7-d₄-2,6-dimethylhepta-1,5-diene) to improve metabolic stability while retaining bioactivity.

Emerging applications extend to biomaterials, where 2,6-dimethylhepta-1,5-diene serves as a crosslinker in stimuli-responsive hydrogels. A 2024 Advanced Materials publication highlighted its role in creating redox-sensitive drug delivery systems that release payloads in tumor microenvironments (GSH > 10 mM). The compound's low cytotoxicity (IC₅₀ > 200 μM in HEK293 cells) further supports its biomedical utility.

Ongoing challenges include optimizing stereoselective synthesis routes and addressing solubility limitations through prodrug strategies. Current research priorities, as outlined in a recent Nature Reviews Chemistry perspective (2024), focus on harnessing its diene reactivity for targeted covalent inhibitor design and bioorthogonal chemistry applications.

• 2146-37-4(Ethylidenecyclopentane)
• 111-02-4(Squalene)
• 7683-64-9(2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene)
• 591-49-1(1-Methyl-cyclohexene)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)